Month: August 2021

Ashland board authorizes quarterly dividend

Written by Customer Service on August 5, 2021. Posted in Dividend Reports And Estimates.

WILMINGTON, Del., Aug. 05, 2021 (GLOBE NEWSWIRE) — The board of directors of Ashland Global Holdings Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.30 per share on the company’s common stock. The dividend is payable on September 15, 2021, to stockholders of record at the close of business on September 1, 2021. As of July 31, 2021, there were 60,734,468 shares of Ashland common stock outstanding. About Ashland Ashland Global Holdings Inc. (NYSE: ASH) is a premier specialty materials company with a conscious and proactive mindset for sustainability. The company serves customers in a wide range of consumer and industrial markets, including adhesives, architectural coatings, automotive, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceutical. Approximately 4,200 passionate, tenacious...

IES Holdings Reports Fiscal 2021 Third Quarter Results

Written by Customer Service on August 5, 2021. Posted in Public Companies.

HOUSTON, Aug. 05, 2021 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter ended June 30, 2021. Third Quarter 2021 HighlightsRevenue of $406 million for the third quarter of fiscal 2021, an increase of 38% compared with $293 million for the same quarter of fiscal 2020 Operating income of $22.5 million for the third quarter of fiscal 2021, an increase of 60% compared with $14.1 million for the same quarter of fiscal 2020 Net income attributable to IES increased 57% to $19.3 million for the third quarter of fiscal 2021, compared with $12.3 million for the same quarter of fiscal 2020; diluted earnings per share attributable to common stockholders of $0.92 compared with $0.58 for the third fiscal quarters of 2021 and 2020, respectively Adjusted net income...

Intelligent Systems Reports Second Quarter 2021 Results

Written by Customer Service on August 5, 2021. Posted in Public Companies.

NORCROSS, Ga., Aug. 05, 2021 (GLOBE NEWSWIRE) — Intelligent Systems Corporation [NYSE: INS], the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, announced today its financial results for the quarter ended June 30, 2021. “Our strong momentum continued into the second quarter of fiscal 2021, led by CoreCard’s flexible and agile platform in a constantly shifting environment,” said Leland Strange, CEO of Intelligent Systems. “As expected, we recognized $2.3 million in license revenue, and the total revenue for the quarter increased 66% year-over-year to $13.4 million. Our substantial top-line growth more than offset higher costs associated with our infrastructure and platform investments and resulted in meaningful growth in income from operations and...

Allarity Therapeutics’ oral PARP inhibitor, Stenoparib, demonstrates additional pre-clinical antiviral activity against new variants of Coronavirus

Written by Customer Service on August 5, 2021. Posted in Public Companies.

Current positive results with 3 variants, including alpha variant B.1.1.7 (“British” variant), beta variant B.1351 (“South African” variant) and gamma variant P.1 (“Brazilian” variant), follows prior pre-clinical tests indicating efficacy of the novel PARP inhibitor stenoparib against SARS-Cov-2Allarity Therapeutics is initiating further testing of stenoparib against delta variant B.1.617.2 (“Indian” variant)Press Release Hørsholm, Denmark (August 5, 2021) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced positive results from the further pre-clinical testing of the antiviral activity of its PARP inhibitor, stenoparib, against Coronavirus variant B.1.1.7 (British variant). The Pathogen and Microbiome Institute at Northern Arizona University (NAU), a leading U.S. infectious disease research center, conducted...

Atea Pharmaceuticals to Host Second Quarter Financial Results Conference Call on August 12, 2021

Written by Customer Service on August 5, 2021. Posted in Public Companies.

BOSTON, Aug. 05, 2021 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that it will host a live conference call and audio webcast on Thursday, August 12, 2021 at 4:30 p.m. ET to report financial results for the second quarter ended June 30, 2021, and to provide a clinical and corporate update. To access the live conference call, please dial (833) 301-1150 (domestic) or (914) 987-7391 (international) at least five minutes prior to the start time, and refer to conference ID 5795073. A live audio webcast of the call and accompanying slide presentation will be available in the Investors’ Events & Presentations section of the Company’s website, www.ateapharma.com. An archived webcast will be available on the Atea website approximately two hours...

REMINDER/Saputo Inc.: 2021 Annual Meeting of Shareholders and Fiscal 2022 First Quarter Results

Written by Customer Service on August 5, 2021. Posted in Public Companies.

Webcast and conference call for analysts and institutional investors MONTREAL, Aug. 05, 2021 (GLOBE NEWSWIRE) — Saputo Inc. (TSX:SAP) – Saputo Inc.’s Annual Meeting of Shareholders will be held in a virtual-only format on Thursday, August 5, 2021, at 10 a.m. (Eastern Time), via live webcast at: https://web.lumiagm.com/486765661. The speakers will be:Mr. Lino A. Saputo, Chair of the Board and Chief Executive Officer; Mr. Kai Bockmann, President and Chief Operating Officer, Saputo Inc. and International Sector; Mr. Maxime Therrien, Chief Financial Officer and Secretary.Fiscal 2022 First Quarter ResultsSaputo will release its fiscal 2022 first quarter financial results on Thursday, August 5, 2021. A webcast and conference call for analysts and institutional investors will follow at 1 p.m. (Eastern Time). The webcast will...

ProQR Announces Second Quarter 2021 Operating and Financial Results

Written by Customer Service on August 5, 2021. Posted in Public Companies.

Top-line data from Phase 2/3 pivotal Illuminate trial of sepofarsen for CEP290-mediated LCA10 on track for H1 2022 QR-421a pivotal Sirius and Celeste Phase 2/3 trials in Usher syndrome and retinitis pigmentosa expected to start by year end 2021 Initial clinical data from Phase 1/2 Aurora trial of QR-1123 for autosomal dominant retinitis pigmentosa expected in Q4 2021LEIDEN, Netherlands & CAMBRIDGE, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today reported its financial and operating results for the second quarter ended June 30, 2021, and provided a business update. “Across our pipeline, on the partnering front, and with our balance sheet, we have generated...

Jounce Therapeutics Reports Second Quarter 2021 Financial Results

Written by Customer Service on August 5, 2021. Posted in Public Companies.

– INNATE monotherapy dose escalation enrollment completed and target dose selected, on track to initiate indication specific expansions in third quarter 2021- – Announced two additional LILRB family targets as potential future development candidates – – Ended the quarter with $246.1 million in cash, cash equivalents and investments – – Company to host conference call and webcast today at 8:00 AM ET – CAMBRIDGE, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update. “I am very pleased with the progress Jounce has made this quarter...

Lifetime Brands, Inc. Reports Second Quarter 2021 Financial Results

Written by Customer Service on August 5, 2021. Posted in Public Companies.

Declares Regular Quarterly Dividend GARDEN CITY, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, today reported its financial results for the quarter ended June 30, 2021. Robert Kay, Lifetime’s Chief Executive Officer, commented, “We are pleased to have sustained the momentum we created in the first quarter of 2021 through the second quarter, with net sales up 24.3% and an increase in income from operations of $6.7 million compared to the second quarter of 2020. Demand for our products remains strong, and in addition to delivering another consecutive quarter of growth in our core U.S. business, our international operations continued to improve, driven by the recovery in Europe, growth...

Znergy Appoints Bruce R. Albertson to Board of Directors

Written by Customer Service on August 5, 2021. Posted in Public Companies.

SYRACUSE, IN, Aug. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Znergy, Inc. (OTC PINK: ZNRG) (the” Company”), a leading provider of new LED lighting and turnkey LED lighting conversions for businesses, is pleased to announce the addition of Bruce R. Albertson to the Board of Directors. Bruce Albertson replaces Jennifer Peek, whose business demands and travel schedule prevent her from continuing to fulfill her role with Znergy. Bruce Albertson’s 25-year career with GE included global responsibilities for $6B of business, and while there was the recipient of numerous GE Chairman/CEO awards. He increased exposure of GE’s Brand worldwide and developed new markets, channels, and products for GE. Bruce has a proven track record with new business start-ups and turnaround situations, the most recent being Brown Jordan International...

Month: August 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals